Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM movers: Aptamer Alzheimer’s test success and GCM Resources discount

AIM movers: Yourgene sells Taiwan subsidiary and Sound Energy obtains financing deal

New standard listing: Altona Rare Earths

AIM movers: Quadrise collaboration and Myanmar Investment NAV falls by two-thirds

AO World partners with Frasers Group

New standard listing: Amicorp FS

Aquis weekly movers: ABF bids for National Milk Records

AIM weekly movers: Acuity RM recovers on back of contract

AIM movers: Shoe Zone ahead of expectations and Barryroe Offshore Energy has three weeks to find cash

Financing approach to Amigo

Mercantile Ports & Logistics strengthens balance sheet via placing and offer

Galliford Try settlement dividend

AIM movers: RWS share buy back and ex-dividends

Midwich Group launches retail offer

DX settles with Tuffnells

AIM movers: Jersey Oil & Gas farm-out approved and IOG gas flow problem

Upgraded forecasts for City Pub Group

New standard listing: Ashington Innovation

New standard listing: Becket Invest

Gooch & Housego publishes strategic review

AIM Movers: Barkby’s sleep success and FireAngel Safety Technologies new boss

AIM movers: Tristel gets US FDA approval and DeepVerge still seeking cash

AIM reversal: Modular prospects for Eco Buildings

Kew Soda plans premium listing

Aquis weekly movers: Wishbone Gold awarded grant for drilling

AIM weekly movers: Rockfire Resources encounters high zinc grades

AIM Movers: New Pelatro contract and Amur Minerals considers bid

AIM movers: Westminster Security nears breakeven and ex-dividends

AIM movers: Yu Group trading ahead of expectations and no bid for Purplebricks

AIM movers: Empire Metals discovery and Woodbois requires cash

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020